Condition (MeSH)
Cerebral Amyloid Angiopathy, Familial
ClinicalTrials.gov lists 5 trials for Cerebral Amyloid Angiopathy, Familial or a narrower condition beneath it. Arctic Therapeutics has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Cerebral Amyloid Angiopathy, Familial itself; the rest are tagged with a narrower condition beneath it.
When did Cerebral Amyloid Angiopathy, Familial trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cerebral Amyloid Angiopathy, Familial trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Observational | 4 |
How many Cerebral Amyloid Angiopathy, Familial trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cerebral Amyloid Angiopathy, Familial trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Arctic Therapeutics | 1 |
Which publications cover Cerebral Amyloid Angiopathy, Familial? (3)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial. | Trials | 2023 | Yes |
| NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients. | Nature communications | 2021 | Yes |
| Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry. | Stroke | 2016 | Yes |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.